| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,027 |
2,823 |
$665K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,633 |
7,301 |
$392K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,035 |
2,924 |
$334K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,484 |
2,393 |
$163K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
794 |
710 |
$160K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,756 |
1,691 |
$81K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,707 |
3,536 |
$77K |
| 80053 |
Comprehensive metabolic panel |
3,134 |
2,802 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
994 |
895 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,122 |
3,653 |
$32K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
521 |
495 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
1,023 |
920 |
$23K |
| 87634 |
|
149 |
146 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
256 |
250 |
$13K |
| 74018 |
|
168 |
161 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
164 |
151 |
$11K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
186 |
181 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
567 |
504 |
$8K |
| 81003 |
|
2,791 |
2,550 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,001 |
816 |
$4K |
| 84484 |
|
708 |
534 |
$4K |
| 70450 |
Computed tomography, head or brain; without contrast material |
59 |
56 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
142 |
138 |
$3K |
| 84702 |
|
206 |
180 |
$3K |
| 81025 |
|
393 |
376 |
$3K |
| 83605 |
|
605 |
395 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
542 |
493 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
51 |
48 |
$2K |
| 83880 |
|
119 |
111 |
$2K |
| 83690 |
|
585 |
539 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
42 |
41 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
76 |
68 |
$1K |
| 87040 |
|
194 |
94 |
$964.33 |
| 84145 |
|
72 |
64 |
$781.97 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
94 |
83 |
$744.18 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
204 |
188 |
$711.56 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
70 |
67 |
$437.51 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$353.76 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$353.76 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
525 |
464 |
$347.27 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
66 |
63 |
$269.76 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
183 |
172 |
$244.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
255 |
242 |
$230.68 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14 |
12 |
$208.80 |
| 85610 |
|
75 |
73 |
$156.89 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
41 |
40 |
$131.96 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16 |
15 |
$102.00 |
| 83735 |
|
26 |
24 |
$79.97 |
| 85379 |
|
15 |
14 |
$51.98 |
| 85730 |
|
13 |
13 |
$30.50 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16 |
13 |
$16.30 |
| 86140 |
|
14 |
13 |
$8.88 |
| 36415 |
Collection of venous blood by venipuncture |
747 |
664 |
$8.27 |
| A9270 |
Non-covered item or service |
1,159 |
1,076 |
$0.00 |
| 80047 |
|
16 |
16 |
$0.00 |